Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice.
Obesity is associated with a cluster of metabolic disorders and systemic low-grade inflammation involving multiple organs. Recent findings have suggested that intestine is a key organ altered in response to high fat diet (HFD) feeding. Probiotics mainly lactobacillus strains have earlier been implic...
Main Authors: | Haixiao Shang, Jia Sun, Yong Q Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4849746?pdf=render |
Similar Items
-
Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells
by: Lingling Jia, et al.
Published: (2017-10-01) -
Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice
by: Lingling Jia, et al.
Published: (2017-08-01) -
Effects of Clostridium butyricum on breast muscle lipid metabolism of broilers
by: Xu Zhao, et al.
Published: (2018-10-01) -
Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate
by: Jiaming Liu, et al.
Published: (2015-01-01) -
Biotechnological potential of Clostridium butyricum bacteria
by: Daria Szymanowska-Powałowska, et al.
Published: (2014-09-01)